Actionable news
0
All posts from Actionable news
Actionable news in REGN: Regeneron Pharmaceuticals, Inc.,

Regeneron Pharmaceuticals Inc.

Average Recommendation: Overweight Average Target Price: 477.05
Number of Ratings: 28 Current Quarters Estimate: 2.55
FY Report Date: 12 / 2016 Current Year's Estimate: 11.82
Last Quarter's Earnings: 2.83 Median PE on CY...

More